Cabozantinib for Advanced Hepatocellular Carcinoma in the Latest Real-World Practice: A Multicenter Retrospective Analysis-Reference-Cited by-同舟云学术

Cabozantinib for Advanced Hepatocellular Carcinoma in the Latest Real-World Practice: A Multicenter Retrospective Analysis

Published:2023-07-19 Issue: Volume: Page:
ISSN:2199-1154
Container-title:Drugs - Real World Outcomes
language:en
Short-container-title:Drugs - Real World Outcomes

Author:

Kanzaki Hiroaki,Ogasawara Sadahisa^ORCID,Okubo Tomomi,Itokawa Norio,Yoshino Ryohei,Fujimoto Kentaro,Kogure Tadayoshi,Yumita Sae,Ishino Takamasa,Ogawa Keita,Iwanaga Terunao,Nakagawa Miyuki,Fujiwara Kisako,Kojima Ryuta,Koroki Keisuke,Inoue Masanori,Kobayashi Kazufumi,Kanogawa Naoya,Kiyono Soichiro,Nakamura Masato,Kondo Takayuki,Nakagawa Ryo,Nakamoto Shingo,Muroyama Ryosuke,Itobayashi Ei,Atsukawa Masanori,Kato Jun,Kato Naoya

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Link

https://link.springer.com/content/pdf/10.1007/s40801-023-00379-x.pdf

Reference24 articles.

1. Villanueva A. Hepatocellular carcinoma. N Engl J Med. 2019;380:1450–62.

2. Kokudo N, Hasegawa K, Akahane M, et al. Evidence-based clinical practice guidelines for hepatocellular carcinoma: the Japan Society of Hepatology 2013 update (3rd JSH-HCC guidelines). Hepatol Res. 2015;45.

3. Kudo M, Matsui O, Izumi N, et al. JSH consensus-based clinical practice guidelines for the management of hepatocellular carcinoma: 2014 update by Liver Cancer Study Group of Japan. Liver Cancer. 2014;3:458–68.

4. Kudo M. Japan’s successful model of nationwide hepatocellular carcinoma surveillance highlighting the urgent need for global surveillance. Liver Cancer. 2012;1:141–3.

5. Kawano Y, Sasaki A, Kai S, et al. Short- and long-term outcomes after hepatic resection for hepatocellular carcinoma with concomitant esophageal varices in patients with cirrhosis. Ann Surg Oncol. 2008;15:1670–6.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small molecule tyrosine kinase inhibitors approved for systemic therapy of advanced hepatocellular carcinoma: recent advances and future perspectives;Discover Oncology;2024-07-03

2. Insights in Molecular Therapies for Hepatocellular Carcinoma;Cancers;2024-05-10

3. Cabozantinib;Reactions Weekly;2024-01-20